Gelteq Limited Ordinary Shares (GELS) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Gelteq Limited Ordinary Shares (GELS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $4.0M, listed on NASDAQ, employing roughly 7 people, carrying a beta of 0.08 to the broader market. Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. Led by Nathan Jacob Givoni, public since 2024-10-29.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for GELS as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →